science, genomics, proteomics, drug discovery & development, process purification, pathogen inactivation, immunodiagnostics, dna, rna, small molecules, proteins, pulsetm tubes, pressure, cycling, technology, pct, barocycler, nep3229, lysis disk, rapid pressure changes, bio-physical mechanisms, nucleic acids, transcriptomics, proteomics, nucleic acid purification, molecular purification, macromolecular sequencing, nucleic acid hybridization, pathogen inactivation, nucleic acid hybridization, pathogen inactivation, molecular purification, pressure cycling reactor, pathogen inactivation, bio, sciences

following the sale of substantially all the assets and selected liabilities of its bbi diagnostics and bbi biotech divisions to seracare life sciences, inc. on september 14, 2004, boston biomedica, inc. changed its name to pressure biosciences, inc (pbi). pbi is a publicly traded, early-stage company focused on the development of a novel technology called pressure cycling technology (pct).